Metabolomic profiling of asthma and chronic obstructive pulmonary disease: A pilot study differentiating diseases.

[1]  S. Hazen,et al.  Biomarker-based asthma phenotypes of corticosteroid response. , 2015, The Journal of allergy and clinical immunology.

[2]  A. Litonjua,et al.  Asthma, allergy, and responses to methyl donor supplements and nutrients. , 2014, The Journal of allergy and clinical immunology.

[3]  S. Kato,et al.  The progression of comorbidity in IL-18 transgenic chronic obstructive pulmonary disease mice model. , 2014, Biochemical and biophysical research communications.

[4]  G. Valdivia,et al.  Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. , 2014, Chest.

[5]  J. Brehm,et al.  Diet and asthma: vitamins and methyl donors. , 2013, The Lancet. Respiratory medicine.

[6]  M. Amann,et al.  Ascorbate infusion increases skeletal muscle fatigue resistance in patients with chronic obstructive pulmonary disease. , 2013, American journal of physiology. Regulatory, integrative and comparative physiology.

[7]  L. Niskanen,et al.  Hyperglycaemia during exacerbations of asthma and chronic obstructive pulmonary disease , 2013, The clinical respiratory journal.

[8]  Yufu Tang,et al.  Metabonomic Profiling of Serum and Urine by 1H NMR-Based Spectroscopy Discriminates Patients with Chronic Obstructive Pulmonary Disease and Healthy Individuals , 2013, PloS one.

[9]  F. Holguin.  Arginine and Nitric Oxide Pathways in Obesity-Associated Asthma , 2013, Journal of allergy.

[10]  G. Hwang,et al.  Serum metabolomics reveals pathways and biomarkers associated with asthma pathogenesis , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  P. Nair,et al.  Update on clinical inflammometry for the management of airway diseases. , 2013, Canadian respiratory journal.

[12]  W. Busse,et al.  An association between L-arginine/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype. , 2013, American journal of respiratory and critical care medicine.

[13]  B. Yawn,et al.  Inflammation in COPD: implications for management. , 2012, The American journal of medicine.

[14]  M. Jeschke,et al.  Enteral Nutrition Support in Burn Care: A Review of Current Recommendations as Instituted in the Ross Tilley Burn Centre , 2012, Nutrients.

[15]  A. Mirrakhimov.  Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony , 2012, Cardiovascular Diabetology.

[16]  S. Çelik,et al.  Inflammatory Processes and Effects of Continuous Positive Airway Pressure (CPAP) in Overlap Syndrome , 2012, Inflammation.

[17]  E. Kontny,et al.  Taurine and inflammatory diseases , 2012, Amino Acids.

[18]  H. Ohtsu.  Pathophysiologic Role of Histamine: Evidence Clarified by Histidine Decarboxylase Gene Knockout Mice , 2012, International Archives of Allergy and Immunology.

[19]  W. Gerthoffer,et al.  Targeting the restricted α-subunit repertoire of airway smooth muscle GABAA receptors augments airway smooth muscle relaxation. , 2012, American journal of physiology. Lung cellular and molecular physiology.

[20]  S. Hazen,et al.  Urinary bromotyrosine measures asthma control and predicts asthma exacerbations in children. , 2011, The Journal of pediatrics.

[21]  M. Hernandez,et al.  Airway purinergic responses in healthy, atopic nonasthmatic, and atopic asthmatic subjects exposed to ozone , 2011, Inhalation toxicology.

[22]  M. Cho,et al.  The CD4+ T-cell transcriptome and serum IgE in asthma: IL17RB and the role of sex , 2011, BMC pulmonary medicine.

[23]  Erik J. Saude,et al.  Metabolomic profiling of asthma: diagnostic utility of urine nuclear magnetic resonance spectroscopy. , 2011, The Journal of allergy and clinical immunology.

[24]  R. Morty,et al.  Receptor-Mediated Enhancement of Beta Adrenergic Drug Activity by Ascorbate In Vitro and In Vivo , 2010, PloS one.

[25]  Madhukar S. Dasika,et al.  (1)H nuclear magnetic resonance metabolomics analysis identifies novel urinary biomarkers for lung function. , 2010, Journal of proteome research.

[26]  M. Lever,et al.  The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism. , 2010, Clinical biochemistry.

[27]  A. Agustí,et al.  Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients , 2009, European Respiratory Journal.

[28]  D. Wishart,et al.  Exploring Human Metabolites Using the Human Metabolome Database , 2009, Current protocols in bioinformatics.

[29]  Suryanarayana V Vulimiri,et al.  Effects of mainstream cigarette smoke on the global metabolome of human lung epithelial cells. , 2009, Chemical research in toxicology.

[30]  D. Raftery,et al.  Metabolomics-based methods for early disease diagnostics , 2008, Expert review of molecular diagnostics.

[31]  S. Pendharkar,et al.  The clinical significance of exhaled nitric oxide in asthma. , 2008, Canadian respiratory journal.

[32]  Erik J. Saude,et al.  Variation of metabolites in normal human urine , 2007, Metabolomics.

[33]  Brian D. Sykes,et al.  Urine stability for metabolomic studies: effects of preparation and storage , 2007, Metabolomics.

[34]  H. Meurs,et al.  Role of the L-citrulline/L-arginine cycle in iNANC nerve-mediated nitric oxide production and airway smooth muscle relaxation in allergic asthma. , 2006, European journal of pharmacology.

[35]  Erik J. Saude,et al.  Optimization of NMR analysis of biological fluids for quantitative accuracy , 2006, Metabolomics.

[36]  L. Boulet,et al.  Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations , 2006, European Respiratory Journal.

[37]  J. Griffin,et al.  Characterization of the biochemical effects of 1-nitronaphthalene in rats using global metabolic profiling by NMR spectroscopy and pattern recognition , 2005, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[38]  I. Wilson,et al.  Metabonomics, dietary influences and cultural differences: a 1H NMR-based study of urine samples obtained from healthy British and Swedish subjects. , 2004, Journal of pharmaceutical and biomedical analysis.

[39]  R. Böger.  Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor. , 2004, The Journal of nutrition.

[40]  J. Bernier,et al.  Decreased mortality and infectious morbidity in adult burn patients given enteral glutamine supplements: A prospective, controlled, randomized clinical trial* , 2003, Critical care medicine.

[41]  I. Young,et al.  Antioxidants and Oxidative Stress in BAL Fluid of Atopic Asthmatic Children , 2003, Pediatric Research.

[42]  I. Pavord,et al.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.

[43]  G. Becher,et al.  Urinary excretion of leukotriene E4 and eosinophil protein X in children with atopic asthma. , 2000, The European respiratory journal.

[44]  K. Kuroda,et al.  Determination of histamine, 1-methylhistamine and N-methylhistamine by capillary electrophoresis with micelles. , 2000, Biomedical chromatography : BMC.

[45]  Koller,et al.  Assessment of eosinophil granule proteins in various body fluids: is there a relation to clinical variables in childhood asthma? , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[46]  E Holmes,et al.  Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. , 1998, Chemical research in toxicology.

[47]  T. Kumamoto,et al.  Urinary N-methylhistamine in asthmatic children receiving azelastine hydrochloride. , 1997, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[48]  D. Mock,et al.  Increased urinary excretion of 3-hydroxyisovaleric acid and decreased urinary excretion of biotin are sensitive early indicators of decreased biotin status in experimental biotin deficiency. , 1997, The American journal of clinical nutrition.

[49]  W. Vogel,et al.  Levels of amino acids and related compounds in bronchoalveolar lavage fluids of asthmatic patients. , 1997, American journal of respiratory and critical care medicine.

[50]  T. Berglund.  Nicotinamide, a missing link in the early stress response in eukaryotic cells: A hypothesis with special reference to oxidative stress in plants , 1994, FEBS letters.

[51]  R. Urbanek,et al.  Determination of N-methylhistamine in urine as an indicator of histamine release in immediate allergic reactions. , 1990, The Journal of allergy and clinical immunology.

[52]  Lauren L Chen,et al.  Characterization of reactive nitrogen species in allergic asthma. , 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[53]  T. Ahmad,et al.  Altered asymmetric dimethyl arginine metabolism in allergically inflamed mouse lungs. , 2010, American journal of respiratory cell and molecular biology.

[54]  Ethan Y Xu,et al.  Metabolomics in pharmaceutical research and development: metabolites, mechanisms and pathways. , 2009, Current opinion in drug discovery & development.

[55]  Erik J. Saude,et al.  Metabolomic biomarkers in a model of asthma exacerbation: urine nuclear magnetic resonance. , 2009, American journal of respiratory and critical care medicine.

[56]  I. Pavord,et al.  Biomarkers Predicting Response to Corticosteroid Therapy in Asthma , 2005, Treatments in respiratory medicine.

[57]  J. Adamus,et al.  1-Methylnicotinamide: a potent anti-inflammatory agent of vitamin origin. , 2003, Polish journal of pharmacology.

[58]  Elaine Holmes,et al.  Metabonomic applications in toxicity screening and disease diagnosis. , 2002, Current topics in medicinal chemistry.

[59]  E. Wouters,et al.  Plasma and muscle amino acid levels in relation to resting energy expenditure and inflammation in stable chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[60]  S. Yuyama,et al.  The excretion of N1-methyl-2-pyridone-5-carboxylic acid and related compounds in human subjects after oral administration of nicotinic acid, trigonelline and N1-methyl-2-pyridone-5-carboxylic acid. , 1991, Advances in experimental medicine and biology.

[61]  A. Wagenmakers,et al.  The metabolic fate of branched-chain amino acids and 2-oxo acids in rat muscle homogenates and diaphragms. , 1985, The International journal of biochemistry.

[62]  J. Wyczółkowska,et al.  The inhibitory effect of nicotinamide on asthma-like symptoms and eosinophilia in guinea pigs, anaphylactic mast cell degranulation in mice, and histamine release from rat isolated peritoneal mast cells by compound 48-80. , 1974, International archives of allergy and applied immunology.

[63]  Foã Pp,et al.  The urinary excretion of trigonelline- and nicotinic acid-like substances in human subjects after the ingestion of trigonelline and after smoking. , 1946 .